Update: Spot Bio launches with $40M to study non-viral gene therapy for muscular dystrophy

June 17, 2026 07:00 AM EDT FinancingStartups Ex­clu­sive: Spot Bio launch­es with $40M to study mR­NA ther­a­py for mus­cu­lar dy­s­tro­phy Ryan Cross Senior Science Correspondent A start­up with op­er­a­tions in Cal­i­for­nia and Chi­na has qui­et­ly be­gun tests of a ge­net­ic med­i­cine that could re­store dy­s­trophin, the vi­tal mus­cle pro­tein that … Sign up to read this article for free. Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox. SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER